Sign In
Buy K
$83.44
+0 (+0%)
At Close: Mar 09, 2026
Factors to Influence Monster Beverage's (MNST) Q2 Earnings
12:41pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Monster Beverage's (MNST) Q2 results are expected to reflect gains from strong consumer demand for energy drinks, innovation and product launches amid a high cost environment.
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
10:20am, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Style Box ETF report for MOAT
Kellogg's Q2 Preview: 6th Consecutive EPS Beat Inbound?
08:04pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Kellogg shares have been blistering hot year-to-date, increasing nearly 17% in value and crushing the S&P 500's performance.
Kellogg's Q2 Preview: 6th Consecutive EPS Beat Inbound?
05:21pm, Tuesday, 02'nd Aug 2022
Kellogg shares have been blistering hot year-to-date, increasing nearly 17% in value and crushing the S&P 500's performance.
Sysco (SYY) Reports Next Week: Wall Street Expects Earnings Growth
02:00pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Sysco (SYY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kellogg (K) Readies for Q2 Earnings: What's in the Cards?
12:31pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Kellogg's (K) second-quarter 2022 results are likely to reflect gains from the EMEA region's strength and the snacks business, whereas cost inflation is likely to have been a challenge.
Clorox (CLX) Readies for Q4 Earnings: What's in the Cards?
11:40am, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Clorox's (CLX) fourth-quarter fiscal 2022 results are likely to reflect gains from the IGNITE strategy and pricing actions, whereas elevated cost concerns are likely to have affected profits.
Post Holdings (POST) Queued for Q3 Earnings: Things to Note
03:10pm, Monday, 01'st Aug 2022 Zacks Investment Research
Post Holdings' (POST) Q3 performance is likely to reflect adverse impacts from higher raw material, freight and manufacturing costs. Also, supply chain disruptions might be a concern.
Medifast (MED) Readies for Q2 Earnings: What's in the Cards?
12:10pm, Monday, 01'st Aug 2022 Zacks Investment Research
Medifast's (MED) second-quarter 2022 results are likely to reflect gains from its OPTAVIA lifestyle solution and coaching support system, while escalated costs might have been a concern.
What's in Store for Service Corporation (SCI) in Q2 Earnings?
11:46am, Monday, 01'st Aug 2022 Zacks Investment Research
Service Corporation's (SCI) second-quarter 2022 results are likely to reflect higher funeral revenues, whereas elevated costs might have been a deterrent.
Kinross announces senior management changes
09:00pm, Friday, 29'th Jul 2022 GlobeNewswire Inc.
Company appoints new Chief Operating Officer Company appoints new Chief Operating Officer
Kinross announces renewal of share buyback program
09:00pm, Thursday, 28'th Jul 2022 GlobeNewswire Inc.
(All dollar amounts are expressed in U.S. dollars, unless otherwise noted.)
Factors Likely to Decide Carter's (CRI) Fate in Q2 Earnings
03:05pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Carter's (CRI) second-quarter results are likely to reflect the impacts of weak retail sales, high freight costs and supply chain issues. However, online strength and improved price realization act as
Kellogg (K) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
02:02pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Kellogg (K) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kinross Gold Corporation (KGC) CEO Paul Rollinson on Q2 2022 Results - Earnings Call Transcript
01:55pm, Thursday, 28'th Jul 2022
Kinross Gold Corporation (NYSE:KGC ) Q2 2022 esults Earnings Conference Call July 28, 2022 8:00 AM ET Company Participants Chris Lichtenheldt - Vice President, Investor Relations Paul Rollinson - Pres
